These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12867727)

  • 21. Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies.
    Bahloul C; Taieb D; Kaabi B; Diouani MF; Ben Hadjahmed S; Chtourou Y; Imen B'Chir B; Dellagi K
    Epidemiol Infect; 2005 Aug; 133(4):749-57. PubMed ID: 16050522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.
    Gibert R; Alberti M; Poirier B; Jallet C; Tordo N; Morgeaux S
    Vaccine; 2013 Dec; 31(50):6022-9. PubMed ID: 24161572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and calibration of the second batch of OIE anti-rabies positive reference serum.
    Wasniewski M; Barrat J; Fooks AR; Franka R; Müller T; Sabeta C; Cliquet F
    Rev Sci Tech; 2017 Dec; 36(3):779-788. PubMed ID: 30160702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.
    Lin G; Chen S; Zhao H; Liang J; Deng Q; Liang R; Guo X; Chen Z; Chen B; Liu T; Wu Y
    Sci Rep; 2017 Aug; 7(1):7288. PubMed ID: 28779162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.
    Liu Y; Zhang S; Zhang F; Hu R
    Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a relative potency test using ELISA for human rabies vaccines.
    Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
    Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and pre-validation of a quantitative multi-dose serological assay for potency testing of inactivated rabies vaccines for human use.
    Moreira WC; Freitas JFS; Machado NS; Almeida AECC; Moura WC
    J Virol Methods; 2019 Jan; 263():54-59. PubMed ID: 30393149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardisation and establishment of a rabies ELISA test in European laboratories for assessing the efficacy of oral fox vaccination campaigns.
    Cliquet F; Müller T; Mutinelli F; Geronutti S; Brochier B; Selhorst T; Schereffer JL; Krafft N; Burow J; Schameitat A; Schlüter H; Aubert M
    Vaccine; 2003 Jun; 21(21-22):2986-93. PubMed ID: 12798642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
    Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
    Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of a cultured rabies vaccine studied in guinea pigs preliminarily infected with a fixed rabies virus].
    Movsesiants AA; Romanova LN; Tsetlin EM; Shkol'nik RIa; Kolotvina PV; Gribencha SV; Barinskiĭ IF; Kasatkin VV; Sumarokov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):36-9. PubMed ID: 1811386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody.
    Gairola S; Gautam M; Waghmare S
    Hum Vaccin Immunother; 2020 Aug; 16(8):1857-1865. PubMed ID: 31971485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid quantitative assay of rabies post-vaccination antibody by ELISA.
    Karamany RM; Kazar J; Malik SA; al-Mufti S; Badriya M
    APMIS Suppl; 1988; 3():40-3. PubMed ID: 3179075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use.
    Abhinay G; Dessain S; Srikanth A; Senthilkumar RL; Vidyasagar P; Praveen A; Chandrasekhar Reddy RV; Swapna Reddy E; Rajendra L
    Vaccine; 2014 Jan; 32(2):209-13. PubMed ID: 24262315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency testing of inactivated rabies vaccines using a serological method.
    Kamphuis E; Krämer B; Schildger H; Duchow K
    Dev Biol (Basel); 2012; 134():23-7. PubMed ID: 22888591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores.
    Servat A; Feyssaguet M; Blanchard I; Morize JL; Schereffer JL; Boue F; Cliquet F
    J Immunol Methods; 2007 Jan; 318(1-2):1-10. PubMed ID: 17166510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rabies vaccine inactivated with ethylenimine. Duration of the immunity in dogs].
    Larghi OP; Savy VL; Nebel AE; Rodríguez A
    Rev Argent Microbiol; 1979; 11(3):102-7. PubMed ID: 263180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.